Citations for
1CYP2D6, CYP2D6DM
CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
Halling J, Weihe P, Brosen K.
Ther Drug Monit 30(3):271-5. 2008
2CYP2D6, CYP2D6DM, CYP2D7P1
A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine.
Pai HV, Kommaddi RP, Chinta SJ, Mori T, Boyd MR, Ravindranath V.
J Biol Chem 279(26):27383-9. Epub 2004 Mar 29. 2004
3CYP2D6, CYP2D6DM
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.
Saxena R, Shaw GL, Relling MV, Frame JN, Moir DT, Evans WE, Caporaso N, Weiffenbach B.
Hum Mol Genet 3 : 923-926. 1994
4CYP2D6, CYP2D6DM
DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6) : evidence for two major allozymes in extensive metabolisers.
Panserat S, et al.
Hum Genet 94 : 401-406. 1994
5CYP2D6, CYP2D6DM
Debrisoquine/sparteine hydroxylation genotype and phenotype : analysis of common mutations and alleles of CYP2D6 in a european population.
Broly F, et al.
DNA Cell Biol 10 : 545-558. 1991
6CYP2D6, CYP2D6DM
Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification.
Heim M, et al.
Lancet 336 : 529-532. 1990
7CYP2D6, CYP2D6DM
Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.
Kagimoto M, et al.
J Biol Chem 265 : 17209-17214. 1990
8CYP2D6, CYP2D6DM
The human CYP2D locus associated with a common genetic defect in drug oxidation: A G1934-A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site.
Hanioka N, et al.
Am J Hum Genet 47 : 994-1001. 1990
9CYP2D6, CYP2D6DM
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.
Gonzalez FJ, et al.
Nature 331 : 442-446. 1988